Results 191 to 200 of about 9,442,670 (309)

Financing for health: where there's a will…

open access: yesThe Lancet Global Health, 2016
The Lancet Global Health
doaj   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

Contemporary accounts and future directions for decolonising global health: A scoping review. [PDF]

open access: yesPublic Health Pract (Oxf)
Stewart DE   +7 more
europepmc   +1 more source

Top ten global health priorities : Center for Global Health, U.S. Centers for Disease Control and Prevention, 2017

open access: yes
CS272346-AHPublication date from document properties.CDC_Global_Health_Photo_Book-web.pdf1. Working 24/7 TO PROTECT Americans from Global Health Threats -- 2. BOOTS ON THE GROUND : Responding to Global Health Emergencies -- 3.

core  

A role for eIF5A in translational control of stress‐inducible proteins in multiple myeloma cell lines

open access: yesMolecular Oncology, EarlyView.
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both   +7 more
wiley   +1 more source

Assessing Resident Perceptions and Needs: Global Orthopaedic Opportunities in North American Residency Programs. [PDF]

open access: yesJB JS Open Access
MacKechnie MC   +25 more
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

25 million people internally displaced by violence worldwide [PDF]

open access: yesForced Migration Review, 2004
Global IDP Project
doaj  

Home - About - Disclaimer - Privacy